{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:33:09Z","timestamp":1788870789734,"version":"build-2803163510"},"reference-count":10,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T00:00:00Z","timestamp":1428451200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T00:00:00Z","timestamp":1428451200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Special Program Molecular Clinical Oncology, 5\u00a0\u00d7\u00a01000, Milan, Italy"},{"name":"Fondo per gli Investimenti della Ricerca di Base (FIRB), Rome, Italy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1111\/bjh.13448","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T00:37:23Z","timestamp":1428539843000},"page":"884-887","source":"Crossref","is-referenced-by-count":4,"title":["CD45 antigen negativity in T-lineage ALL correlates with\n                    <i>PTPRC<\/i>\n                    mutation and sensitivity to a selective JAK inhibitor"],"prefix":"10.1111","volume":"171","author":[{"given":"Sara","family":"Raponi","sequence":"first","affiliation":[{"name":"Haematology; Department of Cellular Biotechnologies and Haematology; Sapienza University; Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Gianfelici","sequence":"additional","affiliation":[{"name":"Haematology; Department of Cellular Biotechnologies and Haematology; Sapienza University; Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Chiaretti","sequence":"additional","affiliation":[{"name":"Haematology; Department of Cellular Biotechnologies and Haematology; Sapienza University; Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Peragine","sequence":"additional","affiliation":[{"name":"Haematology; Department of Cellular Biotechnologies and Haematology; Sapienza University; Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvia","family":"Brugnoletti","sequence":"additional","affiliation":[{"name":"Haematology; Department of Cellular Biotechnologies and Haematology; Sapienza University; Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria S.","family":"De Propris","sequence":"additional","affiliation":[{"name":"Haematology; Department of Cellular Biotechnologies and Haematology; Sapienza University; Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilisa","family":"Marinelli","sequence":"additional","affiliation":[{"name":"Haematology; Department of Cellular Biotechnologies and Haematology; Sapienza University; Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Hulselmans","sequence":"additional","affiliation":[{"name":"Centre for Human Genetics; KU Leuven; Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stein","family":"Aerts","sequence":"additional","affiliation":[{"name":"Centre for Human Genetics; KU Leuven; Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Geerdens","sequence":"additional","affiliation":[{"name":"Centre for Human Genetics; KU Leuven; Leuven Belgium"},{"name":"Centre for the Biology of Disease; VIB; Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Cools","sequence":"additional","affiliation":[{"name":"Centre for Human Genetics; KU Leuven; Leuven Belgium"},{"name":"Centre for the Biology of Disease; VIB; Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Fo\u00e0","sequence":"additional","affiliation":[{"name":"Haematology; Department of Cellular Biotechnologies and Haematology; Sapienza University; Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Guarini","sequence":"additional","affiliation":[{"name":"Haematology; Department of Cellular Biotechnologies and Haematology; Sapienza University; Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,4,8]]},"reference":[{"key":"10.1111\/bjh.13448-BIB0001|bjh13448-cit-0001","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1182\/blood-2008-11-185132","article-title":"Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)","volume":"113","author":"Bassan","year":"2009","journal-title":"Blood"},{"key":"10.1111\/bjh.13448-BIB0002|bjh13448-cit-0002","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1084\/jem.20072182","article-title":"Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia","volume":"205","author":"Flex","year":"2008","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1111\/bjh.13448-BIB0003|bjh13448-cit-0003","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/35053086","article-title":"CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling","volume":"409","author":"Irie-Sasaki","year":"2001","journal-title":"Nature"},{"key":"10.1111\/bjh.13448-BIB0004|bjh13448-cit-0004","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/sj.leu.2402150","article-title":"BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 concerted action investigation of minimal residual disease in acute leukemia: International Standardization and Clinical Evaluation","volume":"15","author":"Lucio","year":"2001","journal-title":"Leukemia"},{"key":"10.1111\/bjh.13448-BIB0005|bjh13448-cit-0005","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/10428190109064596","article-title":"Prognostic impact of CD45 antigen expression in high-risk, childhood B-cell precursor acute lymphoblastic leukemia","volume":"42","author":"Nakamura","year":"2001","journal-title":"Leukemia & Lymphoma"},{"key":"10.1111\/bjh.13448-BIB0006|bjh13448-cit-0006","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1182\/blood-2011-09-379958","article-title":"Mutation of the receptor tyrosine phosphatase PTPRC (CD45) in T-cell acute lymphoblastic leukemia","volume":"119","author":"Porcu","year":"2012","journal-title":"Blood"},{"key":"10.1111\/bjh.13448-BIB0007|bjh13448-cit-0007","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s002770050424","article-title":"Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia","volume":"77","author":"Ratei","year":"1998","journal-title":"Annals of Hematology"},{"key":"10.1111\/bjh.13448-BIB0008|bjh13448-cit-0008","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cellsig.2009.10.003","article-title":"Modulation of immune cell signalling by the leukocyte common tyrosine phosphatase, CD45","volume":"22","author":"Saunders","year":"2010","journal-title":"Cellular Signaling"},{"key":"10.1111\/bjh.13448-BIB0009|bjh13448-cit-0009","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1309\/AJCP8G5RMTWUEMUU","article-title":"Characterization of immunophenotypic aberrancies in 200 cases of B acute lymphoblastic leukemia","volume":"132","author":"Seegmiller","year":"2009","journal-title":"American Journal of Clinical Pathology"},{"key":"10.1111\/bjh.13448-BIB0010|bjh13448-cit-0010","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1124\/dmd.110.033787","article-title":"Metabolism, excretion, and pharmacokinetics of [14C]INCB018424, a selective Janus tyrosine kinase 1\/2 inhibitor, in humans","volume":"38","author":"Shilling","year":"2010","journal-title":"Drug Metabolism and Disposition"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjh.13448","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjh.13448","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjh.13448\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T04:41:35Z","timestamp":1625373695000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.13448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,8]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,12]]}},"URL":"https:\/\/doi.org\/10.1111\/bjh.13448","archive":["Portico"],"relation":{},"ISSN":["0007-1048"],"issn-type":[{"value":"0007-1048","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4,8]]}}}